AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
UNRAVELING MYSTERIES OF NEUROBLASTOMA
Authors: WOODS WG
Citation: Wg. Woods, UNRAVELING MYSTERIES OF NEUROBLASTOMA, Lancet, 352(9129), 1998, pp. 667-668
SCREENING INFANTS FOR NEUROBLASTOMA DOES NOT REDUCE THE INCIDENCE OF POOR-PROGNOSIS DISEASE
Authors: WOODS WG TUCHMAN M BERNSTEIN M LEMIEUX B
Citation: Wg. Woods et al., SCREENING INFANTS FOR NEUROBLASTOMA DOES NOT REDUCE THE INCIDENCE OF POOR-PROGNOSIS DISEASE, Medical and pediatric oncology, 31(5), 1998, pp. 450-454
COMPLIANCE IN A SCREENING-PROGRAM FOR NEUROBLASTOMA
Authors: CAMPION P WOODS WG LEMIEUX B
Citation: P. Campion et al., COMPLIANCE IN A SCREENING-PROGRAM FOR NEUROBLASTOMA, Preventive medicine, 27(4), 1998, pp. 590-596
PATHOLOGY REVIEW OF SCREENING NEGATIVE NEUROBLASTOMAS - A REPORT FROMTHE QUEBEC-NEUROBLASTOMA-SCREENING-PROJECT
Authors: KAWAKAMI T MONOBE Y MONFORTE H WOODS WG TUCHMAN M LEMIEUX B BRISSON L BERNSTEIN M BROSSARD J LECLERC JM BYRNE TD TRICHE TJ SHIMADA H
Citation: T. Kawakami et al., PATHOLOGY REVIEW OF SCREENING NEGATIVE NEUROBLASTOMAS - A REPORT FROMTHE QUEBEC-NEUROBLASTOMA-SCREENING-PROJECT, Cancer, 83(3), 1998, pp. 575-581
DISTINCTIVE DEMOGRAPHY, BIOLOGY, AND OUTCOME OF ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN CHILDREN WITH DOWN-SYNDROME - CHILDRENS CANCER GROUP STUDIES 2861 AND 2891
Authors: LANGE BJ KOBRINSKY N BARNARD DR ARTHUR DC BUCKLEY JD HOWELLS WB GOLD S SANDERS J NEUDORF S SMITH FO WOODS WG
Citation: Bj. Lange et al., DISTINCTIVE DEMOGRAPHY, BIOLOGY, AND OUTCOME OF ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN CHILDREN WITH DOWN-SYNDROME - CHILDRENS CANCER GROUP STUDIES 2861 AND 2891, Blood, 91(2), 1998, pp. 608-615
SCREENING FOR NEUROBLASTOMA IS INEFFECTIVE IN REDUCING THE INCIDENCE OF UNFAVORABLE ADVANCED-STAGE DISEASE IN OLDER CHILDREN
Authors: WOODS WG TUCHMAN M ROBISON LL BERNSTEIN M LECLERC JM BRISSON LC BROSSARD J HILL G SHUSTER J LUEPKER R BYRNE T WEITZMAN S BUNIN G LEMIEUX B BRODEUR GM
Citation: Wg. Woods et al., SCREENING FOR NEUROBLASTOMA IS INEFFECTIVE IN REDUCING THE INCIDENCE OF UNFAVORABLE ADVANCED-STAGE DISEASE IN OLDER CHILDREN, European journal of cancer, 33(12), 1997, pp. 2106-2112
INCIDENCE AND MORTALITY OF NEUROBLASTOMA IN CANADA COMPARED WITH OTHER CHILDHOOD CANCERS
Authors: GAO RN LEVY IG WOODS WG COOMBS BA GAUDETTE LA HILL GB
Citation: Rn. Gao et al., INCIDENCE AND MORTALITY OF NEUROBLASTOMA IN CANADA COMPARED WITH OTHER CHILDHOOD CANCERS, CCC. Cancer causes & control, 8(5), 1997, pp. 745-754
CONSTRUCTION AND ANALYSIS OF A RECOMBINATION-DEFICIENT (RADA) MUTANT OF HALOFERAX-VOLCANII
Authors: WOODS WG DYALLSMITH ML
Citation: Wg. Woods et Ml. Dyallsmith, CONSTRUCTION AND ANALYSIS OF A RECOMBINATION-DEFICIENT (RADA) MUTANT OF HALOFERAX-VOLCANII, Molecular microbiology, 23(4), 1997, pp. 791-797
THE CHEMISTRY OF BORON AND ITS SPECIATION IN PLANTS
Authors: POWER PP WOODS WG
Citation: Pp. Power et Wg. Woods, THE CHEMISTRY OF BORON AND ITS SPECIATION IN PLANTS, Plant and soil, 193(1-2), 1997, pp. 1-13
GUIDELINES FOR THE PEDIATRIC CANCER CENTER AND ROLE OF SUCH CENTERS IN DIAGNOSIS AND TREATMENT
Authors: SANDERS J GLADER B CAIRO M FINKLESTEIN JZ FORMAN E GREEN D LUBAN N BLEYER WA LAMPKIN BC MURPHY SB WOODS WG
Citation: J. Sanders et al., GUIDELINES FOR THE PEDIATRIC CANCER CENTER AND ROLE OF SUCH CENTERS IN DIAGNOSIS AND TREATMENT, Pediatrics, 99(1), 1997, pp. 139-141
HIGH BIRTH-WEIGHT AND RISK OF SPECIFIC CHILDHOOD CANCERS - A REPORT FROM THE CHILDRENS CANCER GROUP
Authors: YEAZEL MW ROSS JA BUCKLEY JD WOODS WG RUCCIONE K ROBISON LL
Citation: Mw. Yeazel et al., HIGH BIRTH-WEIGHT AND RISK OF SPECIFIC CHILDHOOD CANCERS - A REPORT FROM THE CHILDRENS CANCER GROUP, The Journal of pediatrics, 131(5), 1997, pp. 671-677
PROGNOSTIC FACTORS (PF) IN CHILDREN WITH ACUTE MYELOID-LEUKEMIA (AML)- RESULTS OF CHILDRENS CANCER GROUP (CCG) PROTOCOL-2891
Authors: SMITH FO HOWELLS WB BUCKLEY JD ARTHUR DC BARNARD DR LANGE BL KOBRINSKY N SANDERS J NEUDORF S GOLD S DESWARTE J DUSENBERRY K WOODS WG
Citation: Fo. Smith et al., PROGNOSTIC FACTORS (PF) IN CHILDREN WITH ACUTE MYELOID-LEUKEMIA (AML)- RESULTS OF CHILDRENS CANCER GROUP (CCG) PROTOCOL-2891, Blood, 90(10), 1997, pp. 2498-2498
MLL GENE REARRANGEMENT, CYTOGENETIC 11Q23 ABNORMALITIES, AND EXPRESSION OF THE NG2 MOLECULE IN INFANT ACUTE MYELOID-LEUKEMIA
Authors: HILDEN JM SMITH FO FRESTEDT JL MCGLENNEN R HOWELLS WB SORENSEN PHB ARTHUR DC WOODS WG BUCKLEY J BERNSTEIN ID KERSEY JH
Citation: Jm. Hilden et al., MLL GENE REARRANGEMENT, CYTOGENETIC 11Q23 ABNORMALITIES, AND EXPRESSION OF THE NG2 MOLECULE IN INFANT ACUTE MYELOID-LEUKEMIA, Blood, 89(10), 1997, pp. 3801-3805
REVIEW OF POSSIBLE BORON SPECIATION RELATING TO ITS ESSENTIALITY
Authors: WOODS WG
Citation: Wg. Woods, REVIEW OF POSSIBLE BORON SPECIATION RELATING TO ITS ESSENTIALITY, The Journal of trace elements in experimental medicine, 9(4), 1996, pp. 153-163
MORPHOLOGIC, IMMUNOLOGICAL, AND CYTOGENETIC CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN CHILDHOOD - A REPORT FROM THE CHILDRENS CANCER GROUP
Authors: BARNARD DR KALOUSEK DK WIERSMA SR LANGE BJ BENJAMIN DR ARTHUR DC BUCKLEY JD KOBRINSKY N NEUDORI S SANDERS J MILLER LP DESWARTE J SHINA DC HAMMOND GD WOODS WG
Citation: Dr. Barnard et al., MORPHOLOGIC, IMMUNOLOGICAL, AND CYTOGENETIC CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN CHILDHOOD - A REPORT FROM THE CHILDRENS CANCER GROUP, Leukemia, 10(1), 1996, pp. 5-12
AUTOLOGOUS BONE-MARROW TRANSPLANTATION EV ACUTE MYELOID-LEUKEMIA - THE UNIVERSITY-OF-MINNESOTA EXPERIENCE
Authors: DUSENBERY KE STEINBUCH M MCGLAVE PB RAMSAY NKC BLAZAR BR NEGLIA JP LITZ C KERSEY JH WOODS WG
Citation: Ke. Dusenbery et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION EV ACUTE MYELOID-LEUKEMIA - THE UNIVERSITY-OF-MINNESOTA EXPERIENCE, International journal of radiation oncology, biology, physics, 36(2), 1996, pp. 335-343
A POPULATION-BASED STUDY OF THE USEFULNESS OF SCREENING FOR NEUROBLASTOMA
Authors: WOODS WG TUCHMAN M ROBISON LL BERNSTEIN M LECLERC JM BRISSON LC BROSSARD J HILL G SHUSTER J LUEPKER R BYRNE T WEITZMAN S BUNIN G LEMIEUX B
Citation: Wg. Woods et al., A POPULATION-BASED STUDY OF THE USEFULNESS OF SCREENING FOR NEUROBLASTOMA, Lancet, 348(9043), 1996, pp. 1682-1687
PLEUROPULMONARY BLASTOMA - A MARKER FOR FAMILIAL DISEASE
Authors: PRIEST JR WATTERSON J STRONG L WOODS WG BYRD RL FRIEND SH NEWSHAM I AMYLON MD PAPPO A MAHONEY DH LANGSTON C HEYN R KOHUT G FREYER DR BOSTROM B RICHARDSON MS BARREDO J DEHNER LP
Citation: Jr. Priest et al., PLEUROPULMONARY BLASTOMA - A MARKER FOR FAMILIAL DISEASE, The Journal of pediatrics, 128(2), 1996, pp. 220-224
DIHYDROLIPOAMIDE DEHYDROGENASE FROM THE HALOPHILIC ARCHAEON HALOFERAX-VOLCANII - HOMOLOGOUS OVEREXPRESSION OF THE CLONED GENE
Authors: JOLLEY KA RAPAPORT E HOUGH DW DANSON MJ WOODS WG DYALLSMITH ML
Citation: Ka. Jolley et al., DIHYDROLIPOAMIDE DEHYDROGENASE FROM THE HALOPHILIC ARCHAEON HALOFERAX-VOLCANII - HOMOLOGOUS OVEREXPRESSION OF THE CLONED GENE, Journal of bacteriology, 178(11), 1996, pp. 3044-3048
THE HUMAN HOMOLOG OF RAT NG2, A CHONDROITIN SULFATE PROTEOGLYCAN, IS NOT EXPRESSED ON THE CELL-SURFACE OF NORMAL HEMATOPOIETIC-CELLS BUT ISEXPRESSED BY ACUTE MYELOID-LEUKEMIA BLASTS FROM POOR-PROGNOSIS PATIENTS WITH ABNORMALITIES OF CHROMOSOME BAND 11Q23
Authors: SMITH FO RAUCH C WILLIAMS DE MARCH CJ ARTHUR D HILDEN J LAMPKIN BC BUCKLEY JD BUCKLEY CV WOODS WG DINNDORF PA SORENSEN P KERSEY J HAMMOND D BERNSTEIN ID
Citation: Fo. Smith et al., THE HUMAN HOMOLOG OF RAT NG2, A CHONDROITIN SULFATE PROTEOGLYCAN, IS NOT EXPRESSED ON THE CELL-SURFACE OF NORMAL HEMATOPOIETIC-CELLS BUT ISEXPRESSED BY ACUTE MYELOID-LEUKEMIA BLASTS FROM POOR-PROGNOSIS PATIENTS WITH ABNORMALITIES OF CHROMOSOME BAND 11Q23, Blood, 87(3), 1996, pp. 1123-1133
NEONATAL SCREENING AND MANAGEMENT OF BIOLOGICALLY LOW-RISK LOCALIZED NEUROBLASTOMA - REPLY
Authors: WOODS WG BERNSTEIN ML
Citation: Wg. Woods et Ml. Bernstein, NEONATAL SCREENING AND MANAGEMENT OF BIOLOGICALLY LOW-RISK LOCALIZED NEUROBLASTOMA - REPLY, Journal of pediatric hematology/oncology, 17(2), 1995, pp. 181-181
CELL-SURFACE EXPRESSION OF THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN (P-170) AS DETECTED BY MONOCLONAL-ANTIBODY MRK-16 IN PEDIATRIC ACUTE MYELOID-LEUKEMIA FAILS TO DEFINE A POOR PROGNOSTIC GROUP - A REPORT FROM THE CHILDRENS CANCER GROUP
Authors: SIEVERS EL SMITH FO WOODS WG LEES JW BLEYER WA WILLMAN CL BERNSTEIN ID
Citation: El. Sievers et al., CELL-SURFACE EXPRESSION OF THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN (P-170) AS DETECTED BY MONOCLONAL-ANTIBODY MRK-16 IN PEDIATRIC ACUTE MYELOID-LEUKEMIA FAILS TO DEFINE A POOR PROGNOSTIC GROUP - A REPORT FROM THE CHILDRENS CANCER GROUP, Leukemia, 9(12), 1995, pp. 2042-2048
USE OF INTRACAVITARY CISPLATIN FOR THE TREATMENT OF CHILDHOOD SOLID TUMORS IN THE CHEST OR ABDOMINAL-CAVITY
Authors: BOYER MW MOERTEL CL PRIEST JR WOODS WG
Citation: Mw. Boyer et al., USE OF INTRACAVITARY CISPLATIN FOR THE TREATMENT OF CHILDHOOD SOLID TUMORS IN THE CHEST OR ABDOMINAL-CAVITY, Journal of clinical oncology, 13(3), 1995, pp. 631-636
RANDOMIZED COMPARISON OF CYCLOPHOSPHAMIDE TOTAL-BODY IRRADIATION VERSUS BUSULFAN CYCLOPHOSPHAMIDE CONDITIONING IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA
Authors: DUSENBERY KE DANIELS KA MCCLURE JS MCGLAVE PB RAMSAY NKC BLAZAR BR NEGLIA JP KERSEY JH WOODS WG
Citation: Ke. Dusenbery et al., RANDOMIZED COMPARISON OF CYCLOPHOSPHAMIDE TOTAL-BODY IRRADIATION VERSUS BUSULFAN CYCLOPHOSPHAMIDE CONDITIONING IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA, International journal of radiation oncology, biology, physics, 31(1), 1995, pp. 119-128
IN RESPONSE TO SHANK,B
Authors: DUSENBERY KE WOODS WG
Citation: Ke. Dusenbery et Wg. Woods, IN RESPONSE TO SHANK,B, International journal of radiation oncology, biology, physics, 31(1), 1995, pp. 202-203
Risultati: 1-25 | 26-43